Document is current
Any future updates will be listed below
-
Authors
Iking-Konert, Christof http://orcid.org/0000-0002-8716-3894
Wallmeier, Pia
Arnold, Sabrina
Adler, Sabine
de Groot, Kirsten
Hellmich, Bernhard
Hoyer, Bimba F.
Holl-Ulrich, Konstanze
Ihorst, Gabriele
Kaufmann, Margit
Kötter, Ina
Müller-Ladner, Ulf
Magnus, T.
Rech, Jürgen
Schubach, Fabian
Schulze-Koops, Hendrik
Venhoff, Nils
Wiech, Thorsten
Villiger, Peter
Lamprecht, Peter
-
Funding
Funding for this research was provided by:
Roche
Vifor Pharma
DGRh
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 31 January 2021
Accepted: 10 June 2021
First Online: 31 July 2021
Declarations
:
: The study was approved by the Ethics committee (EC) of the University of Lübeck (EC reference number: 16–306) as well as by the responsible EC of each participating center (See: Research ethics approval). Written informed consent will be obtained from any individual participating in this registry.
: Not applicable.
: PL reports grants from Roche, Vifor and Deutsche Gesellschaft für Rheumatologie (DGRh, German Society for Rheumatology) for the conduct of this study. UML reports advisor/speaker activities for Chugai and Roche. KdG reports advisor/speaker activities for Roche and Vifor. BHe reports advisor/speaker activities for Chugai, GSK, InflaRx, Roche, and Vifor. The other authors declare no conflict of interest with regard to this registry.
